Skip to main navigation
Skip to main content
Skip to Footer
Google Tag Manager
Navigate Novartis
Patients & Caregivers
Healthcare Professionals
Media
Investors
Partners
Society & ESG
Job Seekers
Global
Novartis site directory
Our Company
Our Leadership
Board of Directors
Executive Committee of Novartis
Our Approach
Strategy
Corporate Responsibility
Diversity & Inclusion
Partnering
Culture and Values
Our Business
Global Product Portfolio
Innovative Medicines
Novartis Pharmaceuticals
Novartis Oncology
Sandoz
Media
Newsroom
News Archive
Multimedia Resources
Subscribe to Updates
Investors
Event Calendar
Financial Data
Share Data & Analysis
Shareholder Information
Environmental, Social & Governance
Our Focus
Disease Areas
Cancer
Cardiovascular, Renal & Metabolism
Immunology & Dermatology
Ophthalmology
Neuroscience
Respiratory
Platforms and Technology
Artificial Intelligence
Cell & Gene Therapy
Novartis Stories
Discovery
From Our Labs
Access to Healthcare
Patient Perspectives
People and Culture
Our Impact
Building Trust with Society
Corporate Responsibility
Ethical Standards
Access
Environmental Sustainability
Global Health
Malaria
Sickle Cell Disease
Chagas Disease
Leprosy
Novartis Foundation
ESG Performance and Reporting
Materiality
Environment, Social and Governance
Transparency and Disclosures
Positions on Key Topics
Statements on Key Issues
Our Science
Research & Early Development
Novartis Institutes for BioMedical Research
Research Disease Areas
Postdoc Program
Open Source Science
Drug Development at Novartis
Global Clinical Pipeline
Translational Medicine
Novartis Clinical Trials
Global Product Portfolio
Science Stories
Discovery
From Our Labs
Careers
Your Career
Novartis Career Search
Careers in Digital
Careers in Research
Careers in Procurement
Careers in Health, Safety & Environment
Working at Novartis
Diversity & Inclusion
Culture and Values
Corporate Responsibility
Career Programs
Our Career Programs
Students and Scholars
Novartis Quantitative Sciences Hackathon
Search
Novartis Social Business
View All Stories
Access to Healthcare
Helping people with sickle cell disease, a painful and life-threatening blood disorder
Access to Healthcare
Asian health experts call for final push to wipe out deadliest form of malaria
Access to Healthcare
Novartis Access impact evaluation: progress update on our work with Boston University
Access to Healthcare
African experts call for renewed global drive to beat malaria
Access to Healthcare
Meet Martin Grobusch, malaria fighter
Access to Healthcare
Malaria is still disrupting lives, despite progress
Access to Healthcare
Partnering for improved cancer care around the globe
Access to Healthcare
Living with breast cancer in Uganda
Access to Healthcare
Pioneering business approach expands healthcare in Indian villages
Discovery
Researchers overcome hurdles to test experimental malaria drug
Search Results Navigation
Current page
1
of 3
Page
2
of 3
Page
3
of 3
Next page
next ›
Last page
last »
